Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia

✍ Scribed by Akira Yokota; Genichiro Ishii; Yoshiki Sugaya; Miki Nishimura; Yasushi Saito; Kenichi Harigaya

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 240 KB
• Volume: 16
• Category: Article
• ISSN: 0278-0232
• DOI: 10.1002/(sici)1099-1069(199812)16:4<131::aid-hon631>3.0.co;2-k

✦ Synopsis

CD44 is a cell surface glycoprotein with a number of isoforms generated by alternative splicing of ten 'variant' exons in humans. Variant exon 6-containing isoforms of CD44 (CD44v6) have been implicated in the metastatic potential of rat carcinoma cell lines. Human homologues of CD44v6 are expressed in several tumour types and are involved in their progression. In the present study, we examined the expression of CD44 mRNA in 20 acute myelocytic leukemias by semiquantitative RT-PCR analysis and assessed its prognostic value. In all leukemic cells the predominant isoform was the 'standard' form of CD44 (CD44H), and intense bands were found in eight cases. CD44v6 was expressed in 11 cases, although its levels and those of other variants containing exon v7 through to v10 were much lower than those of CD44H. Isoforms containing exon v4 or v5 could not be detected. The expression of CD44v6 correlated with the death rate from leukemia (p>0•05), but was not related to other risk factors. On the other hand, the intense expression of CD44H did not correlate with the prognosis of leukemia. CD44v6 thus appears to be a marker for the poor prognosis of acute myelocytic leukemia.